熊本大学大学院生命科学研究部 消化器内科学分野

  • ご挨拶
  • お知らせ
    お知らせ一覧
    教室行事
    臨床研究について(オプトアウト)
  • 患者様へ
    外来のご案内
    診療案内
    入院病棟について
    画像検査
    消化器の病気Q&A
    Fib-4index計算サイト
    飲酒習慣スクリーニングテスト
  • 医療従事者の方々へ
    スタッフ紹介
    研究・業績
    診療案内
    学術奨励賞
  • 学生・研修医の皆様へ
    医局見学について
    後期研修・入局のお申込み
  • 消化器内科について
    リンク
    アクセス
  • お問い合わせ

Research & achievements研究・業績

Research paper

Category
  • 研究活動

  • 研究論文和文

  • 研究論文英文

  • 学会発表

  • 主催講演会

2022年度

  • 英文 原著他 (PubMed順)2022年度

    Ischemic change in gastric mucosa due to gastric wall expansion with air supply: Real-time capture in upper gastrointestinal endoscopy

    Digestive Endoscopy / 2022

    Matsuno K ,Sonoda T, Tanaka Y
  • 英文(PubMed順) 2022年度

    Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model

    Front. Virol / 2022

    Kayesh M-E-H, Hashem M-A, Sanada T, Kitab B, Rashid M-H-O, Akter L, Ezzikouri S, Murakami S, Ogawa S, Tanaka Y, Kohara M and Tsukiyama-Kohara K
    Mac-2 Binding Protein Glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa

    J Glob Health / 2022

    Vincent JP, Ndow G, Ogawa S, Ceesay A, Njie R, Sanneh B, Baldeh I, D’Alessandro U, Mendy M, Thursz M, Chemin I, Tanaka Y, Lemoine M, Shimakawa Y
    Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

    J Hepatol 77,P.967-977 / 2022

    Yuen M-F, Heo J, Kumada H, Suzuki F, Suzuki Y, Xie Q, Jia J, Karino Y, Hou J, Chayama K, Imamura M, Lao-Tan J-Y, Lim S-G, Tanaka Y, Xie W, Yoon J-H, Duan Z, Kurosaki M, Sung-Park J, Labio M-E, Kumar R, Kweon Y-O, Yim H-J, Tao Y, Cremer J, Elston R, Davies M, Baptiste-Brown S, Han K, Campbell F-M, Paff M, Theodore D.
    Ischemic change in gastric mucosa due to gastric wall expansion with air supply: Real-time capture in upper gastrointestinal endoscopy

    Digestive Endoscopy / 2022

    Matsuno K ,Sonoda T, Tanaka Y
    Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

    J Hepatol / 2022

    Man Fung Yuen1, Jeong Heo2, Hiromitsu Kumada3, Fumitaka Suzuki3, Yoshiyuki Suzuki4, Qing Xie5, Jidong Jia6, Yoshiyasu Karino7, Jinlin Hou8, Kazuaki Chayama9, Michio Imamura10, Judy Y. Lao-Tan11, SengGee Lim12, Tanaka Y, Wen Xie14, Jung-Hwan Yoon15, Zhongping Duan16, Masayuki Kurosaki17, Sung-Jae Park18, Madalinee Eternity Labio19, Rajneesh Kumar20, Young-Oh Kweon21, Hyung Joon Yim22, Yu Tao23, Jennifer Cremer24, Robert Elston25, Matt Davies26, Sharon Baptiste-Brown27, Kelong Han27, Fiona M. Campbell25, Melanie Paff27, Dickens Theodore24
    Rapid point-of-care test for hepatitis B core-related antigen to diagnose high viral load in resource-limited settings

    Clin Gastroenterol Hepatol / 2022

    Shimakawa Y, Gibril Ndow,3,4 Théo Cerceau,1 Amie Ceesay,3 Atsushi Kaneko,5 Akira Hasegawa,5 Naoki Yamamoto,5 Katsumi Aoyagi,5 Jeanne Perpétue Vincent,1 Takehisa Watanabe,6 Masaya Baba,2 Bakary Sanneh,7 Ignatius Baldeh,7 Ramou Njie,8,9 Umberto D’Alessandro,3 Maimuna Mendy,10 Isabelle Chemin,11 Mark R. Thursz,4 Maud Lemoine,4 and Tanaka Y
    Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation

    J Gastroenterol / 2022

    Suzuki T,Inoue T,Matsuura K,Kusumoto S,Hagiwara S,Ogawa S,Yagi S,Kaneko A,Fujiwara K,Watanabe T,Aoyagi K,Urata Y,Tamori A,Kataoka H,Tanaka Y
    Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.

    J Hepatol. S0168-8278(22)00020-4. / 2022

    Sonneveld MJ, Chiu SM, Park JY, Brakenhoff SM, Kaewdech A, Seto WK, Tanaka Y, Carey I, Papatheodoridi M, van Bömmel F, Berg T, Zoulim F, Ahn SH, Dalekos GN, Erler NS, Höner Zu Siederdissen C, Wedemeyer H, Cornberg M, Yuen MF, Agarwal K, Boonstra A, Buti M, Piratvisuth T, Papatheodoridis G, Chen CH, Maasoumy B; CREATE study group.
    Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assay.

    Hepatol Res / 2022

    Hagiwara S, Kusumoto S, Inoue T, Ogawa S, Narita T, Ito A, Ri M, Komatsu H, Suzuki T, Matsuura K, Yagi S, Kaneko A, Aoyagi K, Iida S, Tanaka Y.
    Blocking neddylation elicits antiviral effect against hepatitis B virus replication.

    Mol Biol Rep 49,P.403-412 / 2022

    Abounouh K, Kayesh MEH, Altawalah H, Kitab B, Murakami S, Ogawa S, Tanaka Y, Dehbi H, Pineau P, Kohara M, Benjelloun S, Tsukiyama-Kohara K, Ezzikouri S.
    Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection.

    Liver Int. 42,P.124-134 / 2022

    Inoue T, Funatsu Y, Ohnishi M, Isogawa M, Kawashima K, Tanaka M, Moriya K, Kawaratani H, Momoda R, Iio E, Nakagawa H, Suzuki Y, Matsuura K, Fujiwara K, Nakajima A, Yoshiji H, Nakayama J, Tanaka Y.
    Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.

    Hepatol Res 52,P.235-246 / 2022

    Atsukawa M, Tsubota A, Kondo C, Toyoda H, Nakamuta M, Takaguchi K, Watanabe T, Hiraoka A, Uojima H, Ishikawa T, Iwasa M, Tada T, Nozaki A, Chuma M, Fukunishi S, Asano T, Ogawa C, Abe H, Kato K, Hotta N, Shima T, Matsuura K, Mikami S, Tachi Y, Fujioka S, Okubo H, Shimada N, Tani J, Morishita A, Hidaka I, Moriya A, Tsuji K, Akahane T, Okubo T, Arai T, Kitamura M, Morita K, Kawata K, Tanaka Y, Kumada T, Iwakiri K; KTK49 Liver Study Group.
    Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.

    Sci Rep. 12,P.1517 / 2022

    Nakano M, Yatsuhashi H, Bekki S, Takami Y, Tanaka Y, Yoshimaru Y, Honda K, Komorizono Y, Harada M, Shibata M, Sakisaka S, Shakado S, Nagata K, Yoshizumi T, Itoh S, Sohda T, Oeda S, Nakao K, Sasaki R, Yamashita T, Ido A, Mawatari S, Nakamuta M, Aratake Y, Matsumoto S, Maeshiro T, Goto T, Torimura T.
    Mac-2-Binding Protein Glycan Isomer Predicts All Malignancies Post-sustained Virological Response in Chronic Hepatitis C

    Hepatol Commun / 2022

    Kawata K, Atsukawa M, Ohta K, Chida T, Noritake H, Arai T, Iwakiri K, Yasuda S, Toyoda H, Okubo T, Hiraoka A, Watanabe T, Uojima H, Nozaki A, Tani J, Morishita A, Kageyama F, Sasada Y, Nagasawa M, Matsushita M, Oyaizu T, Mikami S, Ikegami T, Abe H, Matsuura K, Tanaka Y, Tsubota A
    Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study

    United European Gastroenterol J 10,P.93-103 / 2022

    Kishino T, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Kaise M.
    Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity

    Hepatol Res 52,P.105-119 / 2022

    Tokunaga T, Tateyama M, Tanaka K, Narahara S, Inada H, Kurano S, Hayashi S, Yoshimaru Y, Nagaoka K , Watanabe T,Setoyama H, Tanaka M, Tanaka Y.
    Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.

    Clin Gastroenterol Hepatol 20,P.874-885.e4 / 2022

    Park J, Le AK, Tseng TC, Yeh ML, Jun DW, Trinh H, Wong G LH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung KS, Toyoda H, Hsu YC, Jeong JY, Yoon EL, Ungtrakul T, Zhang J, Xie Q, Ahn SB, Enomoto M, Shim JJ, Cunningham C, Jeong SW, Cho YK, Ogawa E, Huang R, Lee DH, Takahashi H, Tsai PC, Huang CF, Dai CY, Tseng, Yasuda S, Kozuka R, Li J, Wong C, Wong CC, Zhao C, Hoang J, Eguchi Y, Wu C, Tanaka Y, Gane E, Tanwandee T, Cheung R, Yuen MF, Lee HS, Yu ML, Kao JH, Yang HI, Nguyen MH.
    Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma.

    Hepatol Res 52,P.93-104 / 2022

    Matsui T, Hamada-Tsutsumi S, Naito Y, Nojima M, Iio E, Tamori A, Kubo S, Ide T, Kondo Y, Eguchi Y, Komori A, Morine Y, Shimada M, Utsunomiya T, Shirabe K, Kimura K, Hiasa Y, Chuaypen N, Tangkijvanich P, Ito-Naiki A, Takahashi S, Ochiya T, Tanaka Y.
  • Greetingご挨拶
  • OPT OUT臨床研究について(オプトアウト)
  • Newsお知らせ
  • Event教室行事
  • Linkリンク
  • Accessアクセス
ⓒ Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University